Brian Huber

home / authors / brian-huber

Brian Huber is vice-president of Therapeutic Areas, Drug Development, and Consulting at ICON.

Articles

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d rendering | Image Credit: © Design Cells - © Design Cells - stock.adobe.com

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

Brian Huber;Tamie Joeckel

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

AAPS PharmSci 360: Challenges in Peptide-Based Drugs

Published: November 12th 2024 | Updated: November 28th 2024

AAPS PharmSci 360: Challenges in Peptide-Based Drugs

Published: November 13th 2024 | Updated: November 28th 2024

Risk-Based Development Supporting Process Qualification for Spray-Dried Dispersion

Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice

Published: November 22nd 2024 | Updated: November 28th 2024

Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: November 22nd 2024 | Updated: November 28th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.